GarcÃa, P.; RodrÃguez-Coello, A.; GarcÃa-Pose, A.; Fernández-López, M.D.C.; Muras, A.; Moscoso, M.; Beceiro, A.; Bou, G.
Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against Salmonella Typhimurium. Vaccines 2025, 13, 659.
https://doi.org/10.3390/vaccines13060659
AMA Style
GarcÃa P, RodrÃguez-Coello A, GarcÃa-Pose A, Fernández-López MDC, Muras A, Moscoso M, Beceiro A, Bou G.
Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against Salmonella Typhimurium. Vaccines. 2025; 13(6):659.
https://doi.org/10.3390/vaccines13060659
Chicago/Turabian Style
GarcÃa, Patricia, Arianna RodrÃguez-Coello, Andrea GarcÃa-Pose, MarÃa Del Carmen Fernández-López, Andrea Muras, Miriam Moscoso, Alejandro Beceiro, and Germán Bou.
2025. "Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against Salmonella Typhimurium" Vaccines 13, no. 6: 659.
https://doi.org/10.3390/vaccines13060659
APA Style
GarcÃa, P., RodrÃguez-Coello, A., GarcÃa-Pose, A., Fernández-López, M. D. C., Muras, A., Moscoso, M., Beceiro, A., & Bou, G.
(2025). Engineering and Evaluation of a Live-Attenuated Vaccine Candidate with Enhanced Type 1 Fimbriae Expression to Optimize Protection Against Salmonella Typhimurium. Vaccines, 13(6), 659.
https://doi.org/10.3390/vaccines13060659
